Detecting Omicron in Rapid Antigen Assays with Meridian’s SARS-CoV-2 Antibody Pair

Meridian has confirmed that the SARS-CoV-2 Nucleocapsid antibody pair (Catalog 9547 & 9548) is capable of detecting the conserved nucleoprotein domain of SARS-CoV-2 variants of interest including Omicron (B.1.1.529) in various commercially available COVID-19 rapid antigen tests.

SARS-CoV-2 Nucleocapsid MAb Pair (9547/9548)
  • Detects all major variants including Omicron
  • In approved FDA and CE-marked assay
  • Produced in gram quantities

To view Meridian’s range of reagent solutions for COVID-19 CLICK HERE

Request your sample today of antibody pair 9547 and 9548!

Request Sample

Download Flyer

Subscribe to our newsletter

Get the latest news within your area of research to your inbox.
Subscribe →